Pricing Log in Create free account

BioAge Labs, Inc. (BIOA) vs Siga Technologies Inc. (SIGA)

BioAge Labs, Inc. and Siga Technologies Inc. are both Drug Manufacturers Specialty & Generic companies. BioAge Labs, Inc. and Siga Technologies Inc. are of similar size ($245.6M and $229.2M). Siga Technologies Inc. has the higher net margin (−5.19% vs −912.3%) and the higher return on invested capital (−14.6% vs −118.3%). Across the 15 metrics below, Siga Technologies Inc. leads on 11 and BioAge Labs, Inc. on 4.

Valuation

Metric BIOA SIGA Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 20.87 4.24 2.11
P/B 0.58 1.38 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA 0.95 n/m 12.58
EV/Sales (9.70) 5.01 2.73
Earnings yield (49.38%) (1.26%) (4.38%)
Free cash flow yield (112.36%) (9.02%) 0.00%

Profitability

Metric BIOA SIGA Drug Manufacturers Specialty & Generic median
Gross margin 100.00% 54.35% 53.94%
Operating margin (1,026.28%) (20.76%) 0.00%
Net margin (912.25%) (5.19%) 0.00%
Free cash flow margin (2,345.11%) (37.58%) 0.00%
Return on equity (28.21%) (1.49%) (0.40%)
Return on assets (26.27%) (1.36%) (3.32%)
Return on invested capital (118.25%) (14.59%) 0.00%

Growth

Metric BIOA SIGA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (70.13%) 10.01%
EPS growth (last fiscal year) 66.21% (60.98%) 49.06%
Revenue growth, 5-year CAGR — (5.42%) 6.74%
Net income growth, 5-year CAGR — (16.20%) 0.00%

Health

Metric BIOA SIGA Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.05
Current ratio 17.19 21.72 2.31
Net debt to EBITDA 3.01 (6.39) 0.97

Dividend

Metric BIOA SIGA Drug Manufacturers Specialty & Generic median
Dividend yield — 0.00% 1.57%
Payout ratio — — 0.27

Size

Metric BIOA SIGA Drug Manufacturers Specialty & Generic median
Market cap 245.55m 229.20m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack